Search

everythinglearnresearchcommunity

for

Search:↓

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib may help treat hair loss in children with alopecia areata.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Pioglitazone use was linked to hair regrowth in a patient with permanent hair loss from cicatricial alopecia.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Wedelolactone may help treat inflammation, infections, cancer, bone loss, and organ damage.

The case emphasizes the need for careful screening in children for insulin resistance and related conditions.

The ginseng cicada decoction effectively reduces atopic dermatitis symptoms and improves quality of life safely.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

JAK inhibitors are effective treatments for alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Janus kinase inhibitors may help treat lichen planopilaris.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Finasteride helps female-pattern hair loss.

Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

Baricitinib effectively treated hair loss and inflammation in a patient with alopecia areata and lichen planopilaris.